GTS Securities’s M.D. Sass Concentrated Value ETF SASS Stock Holding History

GTS Securities’s Portfolio SASS Stock Details SASS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-19,843	Closed	-$460K	–	2023
2026 Q1	$460K	Buy	+19,843	New	+$470K	0.02%	796

Other funds holding SASS

MDSL

M.D. Sass LLC New York $1.53B AUM 30.78% 1-Year Est. Return

GTS Securities's SASS Position: Q2 2026 in Review

GTS Securities sold out of M.D. Sass Concentrated Value ETF (SASS) in Q2 2026, closing a stake of 19,843 shares — an estimated $460K sold.

GTS Securities first reported a position in SASS in Q1 2026 and held it in 1 quarter. The position peaked at $460K in Q1 2026. 1 fund tracked by Wall St. Rank holds SASS as of Q2 2026.

GTS Securities reported no remaining M.D. Sass Concentrated Value ETF position as of Q2 2026 after selling out during the quarter.
GTS Securities sold 19,843 M.D. Sass Concentrated Value ETF shares in Q2 2026, an estimated $460K.
GTS Securities first reported a position in M.D. Sass Concentrated Value ETF in Q1 2026 and held it in 1 quarter.
GTS Securities's M.D. Sass Concentrated Value ETF position peaked at $460K in Q1 2026.
1 fund tracked by Wall St. Rank held M.D. Sass Concentrated Value ETF as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.